Granite Bay Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Granite Bay Wealth Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-22,520	Closed	-$8K	–	80
2023 Q1	$8K	Buy	22,520 +3,400	+18%	+$3.05K	0.01%	75
2022 Q4	$17K	Sell	19,120 -700	-4%	-$929	0.01%	66
2022 Q3	$31K	Hold	19,820	–	–	0.02%	57
2022 Q2	$40K	Sell	19,820 -300	-1%	-$519	0.03%	56
2022 Q1	$47K	Buy	20,120 +3,850	+24%	+$12K	0.04%	61
2021 Q4	$76K	Buy	+16,270	New	+$101K	0.08%	60

Other funds holding SRNE

SlateStone Wealth Jupiter, Florida $1.21B AUM 21.86% 1-Year Est. Return

KLCM Advisors Milwaukee, Wisconsin $1.15B AUM 34.45% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Russell Investments Group

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return